SciELO - Scientific Electronic Library Online

 
vol.28 número2Evolución de la lumbalgia en el paciente oncológico tratado con manejo intervencionista del dolor índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Sociedad Española del Dolor

versão impressa ISSN 1134-8046

Resumo

MEDINA PEREZ, JJ; VEGA ROSAS, GA; MEDINA PEREZ, ME  e  COUBERT PELAYO, SG. Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome. Rev. Soc. Esp. Dolor [online]. 2021, vol.28, n.2, pp.71-75.  Epub 21-Jun-2021. ISSN 1134-8046.  https://dx.doi.org/10.20986/resed.2021.3822/2020.

Objective:

The objective of this study is to eva­luate the efficacy and safety of long-acting tapentadol 100 or 200 mg orally every 24 hours for the treatment of Postlaminectomy Syndrome (SPL) in a series of patients with pain neuropathic in ineffective analgesic treatment.

Material and methods:

A single-center, longitudinal, prospective and observational study was conducted, in which 30 patients were recruited to the pain clinic of a third-level reference center who suffered from SPL and who met all the inclusion criteria; To whom the Brief Pain Inventory questionnaire in its Spanish version and the Lanss Test were applied before and after starting treatment with tapentadol and a student's t was applied to compare the overall effectiveness of the treatment of neuropathic pain.

Results:

Data from 30 patients were analyzed, of which 19 were women (63.3 %) and 11 were men (36.6 %) with a diagnosis of confirmed SPL and the presentation of neuropathic pain, who were divided into two groups. The first group of 13 patients (43.3 %) received tapentadol at 100 mg orally every 24 hours, and the second group of 17 patients (56.6 %) received 200 mg orally every 24 hours for four weeks. They were followed up for 4 weeks and statistically significant improvement (p value = 0.05) was found in the SPL clinic.

Palavras-chave : Neuropathic pain; chronic pain; postla­minectomy syndrome; tapentadol; opioids; orthopedic surgery.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )